Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00765375 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of the Use of Botox on Acne
A Phase 2 study, sponsored by DeNova Research.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00765375: Clinical Trial Phase 2 study, sponsored by DeNova Research.
NCT00765375 is a Phase 2 study that was terminated before completion, run by DeNova Research. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00765375, a Phase 2 study, was terminated before completion, sponsored by DeNova Research.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
• To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)
Primary Outcome
To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)
Interventions
- DRUG Bacteriostatic saline
- DRUG Botulinum Neurotoxin Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Why NCT00765375 stopped before completion
NCT00765375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Bacteriostatic saline is the first listed.
NCT00765375 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00765375 about?
NCT00765375 is a clinical study titled "Safety and Efficacy of the Use of Botox on Acne". • To determine the safety and efficacy of Botox Treatment in subjects with mild to moderate acne vulgaris defined by the Investigator's Global Assessment (IGA)
What is the current status of trial NCT00765375?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2008-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00765375?
The interventions under investigation include: Bacteriostatic saline (DRUG), Botulinum Neurotoxin Type A (DRUG).
Who is sponsoring clinical trial NCT00765375?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00765375's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia